Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-FR
Language English French
Date Updated 2023-06-22 2022-12-09
Drug Identification Number 02509164 02509164
Brand name BENDAMUSTINE HYDROCHLORIDE FOR INJECTION BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Common or Proper name Bendamustine Hydrochloride for Injection House Std. Bendamustine Hydrochloride for Injection House Std.
Company Name JAMP PHARMA CORPORATION JAMP PHARMA CORPORATION
Ingredients BENDAMUSTINE HYDROCHLORIDE BENDAMUSTINE HYDROCHLORIDE
Strength(s) 25MG 25MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 vial x 25 mg 1 vial x 25 mg
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-19 2022-07-19
Estimated end date 2023-12-31 2023-04-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments